4MUNOZ A, CARRERA S, FERREIRO J, et al. Reversible liver toxicity with adjuvant trastuzumab for localized breast cancer[ J]. Ann Oncol, 2007,18(12) :2045 - 2046. 被引量：1
6COUDERC LJ,ANIDES S,FRACHON I,et al. Pulmonary toxicity of chemotherapy and G/GM-CSF: a report of five cases [ J ]. Respir Med, 1999,93 ( 1) :65 - 68. 被引量：1
7SLIMACK N,KLINGE SA,SINGH V,et al. Gemcitabine-associated interstitial pneumonitis: Comprehensiveness and clinical characteristics of FDA and medical literature cases [ J ]. ASCO Meeting Abstracts, 2004,22 (14s) :7229. 被引量：1
8WER MS,O'SHAUGHNESSY JA. Cardiac toxicity of trastuzumab-related regimens in HER2-overexpressing breast cancer [ J ]. Clin Breast Cancer, 2007,7 ( 8 ) :600 - 607. 被引量：1
9KEOHAN M,D'ADAMO D,Q1N L,et al. Analysis of toxicity in a phase Ⅱ study of sorafenib in soft tissue sarcoma (STS)[ J]. ASCO Meeting Abstracts, 2007,25 (18s) : 10061. 被引量：1
10KAPITEIJN E, BRAND A, KROEP J,et al. Sunitinib induced hypertension, thrombotic microangiopathy and reversible posterior leukencephalopathy syndrome [ J ]. Ann Oncol, 2007,18 ( 10 ) : 1745 - 1747. 被引量：1
